The global Ticagrelor market is worth USD 2554.39 million and is expected to increase at a CAGR of 9% from 2017 to 2027. Ticagrelor medicines are used to treat cardiovascular illnesses and other cardiac conditions such as damaged arteries, structural issues, and blood clots. The combination of ticagrelor and aspirin has been shown to minimize the rate of vascular fatalities and myocardial infarctions in patients with the acute coronary syndrome. As a result, ticagrelor medicines have a large market presence and are seeing rapid expansion.
The rising prevalence of cardiovascular diseases is a major driver of the Ticagrelor Market expansion. Furthermore, the growing geriatric population has a direct impact on market growth. Furthermore, rising obesity rates are boosting market demand, resulting in a larger pool of cardiovascular patients. In addition, a growing number of pharma producers are propelling the market forward by introducing novel drugs. Significant investments in R&D activities, fueled by better economic conditions, provide a boost to the market's growth.
Read More @ https://cmiinfopiece.blogspot.com/2021/12/in-2017-global-ticagrelor-market-was.html
